Next Article in Journal
Response Predictivity to Neoadjuvant Therapies in Breast Cancer: A Qualitative Analysis of Background Parenchymal Enhancement in DCE-MRI
Previous Article in Journal
Initial Experience of the Levodopa–Entacapone–Carbidopa Intestinal Gel in Clinical Practice
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
JPM
Volume 11
Issue 4
10.3390/jpm11040255
jpm-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Perspective

Personalized, Predictive, Participatory, Precision, and Preventive (P5) Medicine in Rotator Cuff Tears

by
Umile Giuseppe Longo
1,*,
Arianna Carnevale
1,2,
Carlo Massaroni
2,
Daniela Lo Presti
2,
Alessandra Berton
1,
Vincenzo Candela
1,
Emiliano Schena
2 and
Vincenzo Denaro
1
1
Department of Orthopaedic and Trauma Surgery, Campus Bio-Medico University, Via Álvaro del Portillo, 00128 Rome, Italy
2
Unit of Measurements and Biomedical Instrumentation, Campus Bio-Medico University, Via Álvaro del Portillo, 00128 Rome, Italy
*
Author to whom correspondence should be addressed.
J. Pers. Med. 2021, 11(4), 255; https://doi.org/10.3390/jpm11040255
Submission received: 28 January 2021 / Revised: 21 March 2021 / Accepted: 23 March 2021 / Published: 1 April 2021
Browse Figures
Versions Notes

Abstract

:
Rotator cuff (RC) disease is a common musculoskeletal disorder of the shoulder entailing pain, with reduced functionality and quality of life. The main objective of this study was to present a perspective of the current scientific evidence about personalized, predictive, participatory, precision, and preventive approaches in the management of RC diseases. The personalized, predictive, participatory, precision and preventive (P5) medicine model is an interdisciplinary and multidisciplinary approach that will provide researchers and clinicians with a comprehensive patrimony of knowledge in the management of RC diseases. The ability to define genetic predispositions in conjunction with the evaluation of lifestyle and environmental factors may boost the tailoring of diagnosis and therapy in patients suffering from RC diseases.

Graphical Abstract

1. Introduction

Rotator cuff (RC) disease is a common musculoskeletal disorder of the shoulder entailing pain, reduced functionality, and quality of life [1]. Management of RC diseases is an emerging topic in medicine and surgery that embraces several fields ranging from biology, genetics, biomechanics, economy, statistics, and engineering [2,3,4,5,6].
Traditionally, the approach adopted by medicine in the management of diseases has been based on prevention, diagnosis, and treatment [7]. Nowadays, the concept of P5 medicine is becoming a prominent model in the healthcare system [7,8,9].
The P5 medicine approach could provide revolutionary support to orthopaedic surgeons, researchers, and other healthcare professionals in the management of RC injuries, e.g., optimizing clinicians’ decision-making and the choice of the most tailored treatments. At the same time, in this new perspective, the P5 medicine approach could provide to the patients a greater awareness and independence in the management of their health.
RC disease still has many areas of uncertainty [10,11,12,13,14,15,16]. Several aspects related to the etiology of the disease and the optimization of the treatment are still to be optimized. In everyday clinical practice, surgery is offered to patients with a RC injury that is the same for each patient [17,18,19,20]. Generally, the same physiotherapy protocols and surgical techniques are applied to patients who are unique for their characteristics [21,22,23,24].
The main objective of this study was to provide a perspective of the current scientific evidence about personalized, predictive, participatory, precision, and preventive approaches in the management of RC diseases.

2. P5 Medicine

P5 medicine is the evolution of P4 medicine. This last implies a personalized, predictive, preventive, and participatory approach, aiming at determining the best treatments which will be the most suitable for each patient. The “fifth P” has referred to different aspects. The P5 medicine approach has been extended to a population level, i.e., taking into account heritability, which is distinctive for each population, and the public health policy [9,25]. Others proposed the psycho-cognitive aspect as an additional P in the P5 medicine model; namely, a patient is characterized not only by biological and genetic factors, but a person is also a unique individual for his/her attitudes, emotions, and cognitive functions [8,26,27,28,29]. In recent years, precision medicine has gained momentum in health management. What, though, is the difference between precision medicine and personalized medicine? The terms “precision” and “personalized” are often used interchangeably as synonyms, opening broad debates on underlying ethical and social issues [30,31,32,33]. Both approaches propel health management towards a patient-centered model of care [32,34]. Precision medicine applies “omics” science at the population level to identify subgroups of patients that may differ in genetics or biology regarding the development of possible diseases, or that may differ in their response to a particular therapy [35,36]. On the other hand, personalized medicine focuses the attention mainly on the individual—rather than on the general population—also considering contextual factors such as concomitant therapies, metabolism, environment, and lifestyle [35,37].
Compared to traditional medicine, P5 medicine is based on a proactive rather than reactive approach [37]. This subtle distinction implies a relevant meaning that is revolutionizing disease management. Indeed, despite providing interventions during the acute phase of an illness and “re-acting” with treatment and prevention strategies valid for the general population, P5 medicine focuses on a single patient according to a one-dimensional clinical approach [37]. The key aspect of this emerging approach regards the paradigm shift toward increasingly patient-centered medicine, moving beyond the “one size fits all” view (i.e., each treatment has similar effects on the whole population) [7,37].
Also, the confluence of bioinformatics, technological progress, and engineering science with wellness and clinical research is fostering the implementation of intervention programs created ad-hoc for the patient. In this scenario, P5 medicine entails the gathering of a large amount of data for each individual, ranging from medical and clinical history, environmental and social condition, to genomics and biological characteristics [30,37,38]. In Table 1, the definitions of each approach of the P5 medicine model are presented.

3. P5 Medicine in the Management of RC Diseases

An overview of the P5 medicine approach in the management of RC diseases is reported in Table 2 and detailed below.

3.1. Personalized Medicine

Personalized medicine is an aspect of the P5 medicine model that is also gaining momentum in the management of patients with RC diseases. A feature of personalized medicine is evaluating both the variability and unicity of patients in diagnosis and treatment. Research in the orthopedic field is moving towards a better understanding of the musculoskeletal apparatus, bones’ and muscles’ structure and role, applying computational models and innovative imaging techniques [41,52,53]. Telemedicine is a promising solution that aims to provide personalized and supervised therapy, breaking down the patient–therapist distance barrier [46]. Also, this approach of medicine allows for genetic information, comorbidity and biological and psychological aspects to develop more effective interventions for RC diseases [44,47,48].

3.2. Predictive Medicine

Predictive medicine employs systemic approaches founded on endogenous factors, such as genes and genetic variations [44]. It also considers individual aspects, such as environmental and lifestyle exposures. In patients with full-thickness RC tears, levels of pain, health education, and employment status are predictive factors of their emotional and psychological health [42]. Although predictive medicine is conventionally described as techniques and investigations based on genetics, emerging biomedical imaging techniques, machine learning methods, and subject-specific simulations may provide useful information for the definition of predictive models for diagnostic, therapeutic, and surgical scopes [41,43,50,51,52]. MRI analyses have been used in studies aiming to individualize plausible risk factors as predictors for the allocation to surgery of patients with partial-thickness RC tears, or to predict preoperatively retear risks after surgery [45,49].

3.3. Participatory Medicine

Participatory medicine supports and promotes the education of patients in the self-management of their health status. Following this approach, the goal is to intensify the engagement, motivation, and empowerment of the patients, exploiting a multi-centered collaboration that includes clinicians, therapists, or caregivers. The continuous advancements of technology (e.g., wearable sensors, virtual reality, machine learning techniques, and cloud database sharing) are fostering the inclusion of individuals in a collaborative network focused on a more patient-centered and participatory medicine [43,46]. Accurate classifications of movements in patients with RC tears have been proposed using inertial sensors [43]. Wearable systems are excellent candidates for supporting remote patient–clinician relationships and greater adherence to the prescribed home rehabilitation therapy [43,46].

3.4. Precision Medicine

Precision medicine is an evolving field trying to provide a categorization of diseases into subgroups based on genomic information. Musculoskeletal pain is a disabling condition common in patients suffering from RC tears. Precision interventions for shoulder pain have been proposed in a pre-clinical trial supporting the interaction between genetic and biopsychological factors [48]. Moreover, although specific genes (e.g., the estrogen-related receptor β (ESRRB) gene) and genetic variants (e.g., SAP30BP, SASH1) are intrinsic risk factors for RC tearing, other comorbidities may also influence RC disease [44,54].

3.5. Preventive Medicine

Preventive medicine can identify risk factors at both population and individual levels to contrast disease development and adverse outcomes with early interventions and treatments. Inflammatory biomarkers have been used to determine high-risk groups, to prevent shoulder pain by associating the molecular profile with psychological components [48]. Tailored preventive factors may be depicted using computational modeling and advanced imaging techniques to optimize diagnostic and surgical interventions in the management of RC disease [52,53]. Indeed, the early definition of the best treatment may prevent side effects or slow down the progression of the disease.

4. Discussion

This study delineates current scientific evidence in the management of RC diseases in the framework of P5 medicine. The P5 model encompasses personalized, predictive, participatory, precision, and preventive medicine, aiming to figure out the complexity of disease in all its aspects and to use the retrieved information for more patient-centered and individualized care.
To the best of our knowledge, this is the first study that tries to contextualize RC diseases in such an emerging topic as P5 medicine. Previous works have investigated P5 medicine in other research fields, such as oncology [25,26], forensic sciences [55], or autoimmune diseases [9]. Although the “fifth P” in the P5 medicine model has referred to psycho-cognitive features [27] or population-level perspectives [9,56], the common denominator is the same, namely, optimizing wellness for all individuals and their empowerment in the healthcare decision-making process, working closely with clinicians.
The P5 medicine approach seems to be very similar to the traditional medicine perspective. Our findings in RC diseases management confirm that the P5 medicine model’s ultimate goal is the same as that of traditional medicine; the substantial difference is that nowadays, researchers, clinicians, and patients can take advantage of sophisticated investigation techniques provided by emerging technological developments [4,32,34].
In recent decades, telemedicine and eHealth have fostered the application of technologies for promoting wellness and high quality of life [57,58]. An important step forward is that eHealth interventions may have a great potentiality to increase patient engagement [46,59]. eHealth interventions include emerging telecommunication technologies (e.g., smartphones, social media), cloud databases, wearable systems, and mobile technology (i.e., mHealth) [4,8,60]. These facilities could be useful not only to improve patients’ experience and satisfaction, but also for the educational scope to positively impact their lifestyle and care process, and increase adherence to clinicians’ recommendations [39,61].
P5 medicine, in the ongoing era of big data, aspires to delineate tailored prevention, diagnosis, and therapy for each individual [36,62]. Big data concern complex combinations of a huge amount of data deriving from multiple sources and regarding genetics, medical conditions, treatment typology, and demographic and environmental information [34]. Big data analytics and bioinformatics are supported by the engineering, biological, and biomedical sciences, and can be used to identify personalized therapies, as suggested by the P5 medicine approach [30]. Several studies investigated the association between RC diseases and genetic variations [6,63,64,65]. In the era of P5 medicine, biobanks aim to retrieve biological samples (e.g., blood, tissues, RNA, DNA) for therapeutic or research scopes [66].
RC disease is a multifactorial disease in which several components contribute to the disease process, like genetics, lifestyle, and structural features [1,6]. The management of RC tears could greatly benefit from a holistic approach tailored to the patient, optimized by the sophisticated technology available today, to obtain more reliable and efficient results [34].
At present, there is no clear scientific explanation that clarifies why re-rupture may occur after RC surgery in some patients, even with the implementation of the same surgical procedures, restrictions, and postoperative physiotherapy [67]. This unresolved issue justifies the need to develop more personalized medicine for patients with RC disorders [4]. Probably, genetic factors are involved, characterizing the patient’s predisposition [6,67,68]. Moreover, identifying those patients who have a very high probability of RC retear would help both the physician and patients by avoiding recommending surgery to patients with a high probability of failure [36]. In this way, direct and indirect costs could be avoided. On average, recovery after RC surgery can take between six months to one year [69,70,71,72].
Postoperative periods and potential further surgery can lead to serious inconvenience for the patient in daily life, work, interpersonal relationships, and the family environment. Indeed, not all patients with RC tears need surgery [73]. There are many patients with an asymptomatic RC injury, and progression to a pseudo-paralytic shoulder occurs only in a small percentage of cases. Furthermore, there is no correlation between the structural integrity of the RC tendons, shoulder functionality, patient satisfaction, and the ability to carry out the activities of daily living independently [74]. Therefore, applying the principle of predictive medicine to identify patients who have a better chance of recovery with alternative treatments rather than surgery would be of great social value [36].
Furthermore, in the postoperative period, the motivation to perform physiotherapy can be very different. For this reason, telemedicine, remote monitoring of shoulder movements, and gamification could play an essential role in participatory medicine. It could result in increasing patients’ empowerment and engagement, and better outcomes [4,60].
Precision medicine in RC disease could lead to choosing the most suitable treatment for each patient, based on the characteristics of the tendon, fatty degeneration, genetic profile, probability to develop shoulder stiffness, biomarkers, and genomics.
Finally, preventive medicine may reduce the number of patients affected by RC disease. Preventive measures could include changing some environmental and behavioral features. Often, people perform incorrect repetitive movements during sports or at work, leading to an increased risk of developing the disease.
P5 medicine approach in the management of RC tears could have many advantages, but some limitations need to be overcome. The multidisciplinary nature of P5 medicine requires close collaboration between experts in different fields (e.g., orthopedic, genetic, and engineering), and between physicians and patients. Consequently, P5 medicine entails collecting a large amount of heterogeneous data. The collection, analysis, and interpretation of these data could be challenging, as well as the associated costs. Although the implementation of the P5 medicine approach in common clinical practice is challenging, this is a worthwhile effort to make to improve the clinical outcomes of patients with RC tears.

5. Conclusions

The P5 medicine model is an interdisciplinary and multidisciplinary approach that will provide researchers and clinicians with a comprehensive patrimony of knowledge in the management of RC diseases (Figure 1). In this way, the ability to define the genetic predispositions in conjunction with the evaluation of lifestyle and environmental factors may boost the tailoring of the diagnosis and therapy in patients suffering from RC diseases. Future studies embracing clinical research, technology, and public health policy should intertwine more solidly to strengthen the clinician’s decision-making and to promote more individualized care for RC diseases.

Author Contributions

Conceptualization, U.G.L. and A.C.; methodology, U.G.L., A.C., C.M., D.L.P., E.S.; software, A.C., D.L.P.; investigation, U.G.L., A.C., C.M., D.L.P., A.B., V.C., E.S.; resources, U.G.L., V.D.; data curation, A.C.; writing—original draft preparation, A.C.; writing—review and editing, U.G.L., A.C., C.M., D.L.P., A.B., V.C., E.S., and V.D.; supervision, U.G.L., V.D.; project administration, U.G.L.; funding acquisition, U.G.L. All authors have read and agreed to the published version of the manuscript.

Funding

This work has been funded by the Italian Ministry of Health in the framework of RICERCA FINALIZZATA 2016 (PE-2016-02364894).

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Longo, U.G.; Facchinetti, G.; Marchetti, A.; Candela, V.; Risi Ambrogioni, L.; Faldetta, A.; De Marinis, M.G.; Denaro, V. Sleep disturbance and rotator cuff tears: A systematic review. Medicina (Kaunas) 2019, 55, 453. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  2. Longo, U.G.; Berton, A.; Papapietro, N.; Maffulli, N.; Denaro, V. Epidemiology, genetics and biological factors of rotator cuff tears. Med. Sport Sci. 2012, 57, 1–9. [Google Scholar] [PubMed]
  3. Longo, U.G.; Salvatore, G.; Rizzello, G.; Berton, A.; Ciuffreda, M.; Candela, V.; Denaro, V. The burden of rotator cuff surgery in italy: A nationwide registry study. Arch. Orthop. Trauma Surg. 2017, 137, 217–224. [Google Scholar] [CrossRef] [PubMed]
  4. Carnevale, A.; Longo, U.G.; Schena, E.; Massaroni, C.; Lo Presti, D.; Berton, A.; Candela, V.; Denaro, V. Wearable systems for shoulder kinematics assessment: A systematic review. BMC Musculoskelet. Disord. 2019, 20, 546. [Google Scholar] [CrossRef]
  5. Salvatore, G.; Longo, U.G.; Candela, V.; Berton, A.; Migliorini, F.; Petrillo, S.; Ambrogioni, L.R.; Denaro, V. Epidemiology of rotator cuff surgery in italy: Regional variation in access to health care. Results from a 14-year nationwide registry. Musculoskelet. Surg. 2019, 104, 329–335. [Google Scholar] [CrossRef]
  6. Longo, U.G.; Candela, V.; Berton, A.; Salvatore, G.; Guarnieri, A.; DeAngelis, J.; Nazarian, A.; Denaro, V. Genetic basis of rotator cuff injury: A systematic review. BMC Med. Genet. 2019, 20, 149. [Google Scholar] [CrossRef] [Green Version]
  7. Tuena, C.; Semonella, M.; Fernández-Álvarez, J.; Colombo, D.; Cipresso, P. Predictive Precision Medicine: Towards The Computational Challenge. In P5 Ehealth: An Agenda for the Health Technologies of the Future; Springer: Berlin/Heidelberg, Germany, 2020; pp. 71–86. [Google Scholar]
  8. Pravettoni, G.; Triberti, S. A “p5” Approach to Healthcare and Health Technology. In P5 Ehealth: An Agenda for the Health Technologies of the Future; Springer: Berlin/Heidelberg, Germany, 2020; pp. 3–17. [Google Scholar]
  9. Anaya, J.-M.; Duarte-Rey, C.; Sarmiento-Monroy, J.C.; Bardey, D.; Castiblanco, J.; Rojas-Villarraga, A. Personalized medicine. Closing the gap between knowledge and clinical practice. Autoimmun. Rev. 2016, 15, 833–842. [Google Scholar] [CrossRef]
  10. Longo, U.G.; Berton, A.; Ahrens, P.M.; Maffulli, N.; Denaro, V. Clinical tests for the diagnosis of rotator cuff disease. Sports Med. Arthrosc. Rev. 2011, 19, 266–278. [Google Scholar] [CrossRef]
  11. Longo, U.G.; Franceschi, F.; Spiezia, F.; Forriol, F.; Maffulli, N.; Denaro, V. Triglycerides and total serum cholesterol in rotator cuff tears: Do they matter? Br. J. Sports Med. 2010, 44, 948–951. [Google Scholar] [CrossRef]
  12. Longo, U.G.; Franceschi, F.; Ruzzini, L.; Spiezia, F.; Maffulli, N.; Denaro, V. Higher fasting plasma glucose levels within the normoglycaemic range and rotator cuff tears. Br. J. Sports Med. 2009, 43, 284–287. [Google Scholar] [CrossRef]
  13. Franceschi, F.; Longo, U.G.; Ruzzini, L.; Morini, S.; Battistoni, F.; Dicuonzo, G.; Maffulli, N.; Denaro, V. Circulating substance p levels and shoulder joint contracture after arthroscopic repair of the rotator cuff. Br. J. Sports Med. 2008, 42, 742–745. [Google Scholar] [CrossRef]
  14. Denaro, V.; Ruzzini, L.; Longo, U.G.; Franceschi, F.; De Paola, B.; Cittadini, A.; Maffulli, N.; Sgambato, A. Effect of dihydrotestosterone on cultured human tenocytes from intact supraspinatus tendon. Knee Surg. Sports Traumatol. Arthrosc. 2010, 18, 971–976. [Google Scholar] [CrossRef]
  15. Longo, U.G.; Vasta, S.; Maffulli, N.; Denaro, V. Scoring systems for the functional assessment of patients with rotator cuff pathology. Sports Med. Arthrosc. Rev. 2011, 19, 310–320. [Google Scholar] [CrossRef]
  16. Del Buono, A.; Oliva, F.; Longo, U.G.; Rodeo, S.A.; Orchard, J.; Denaro, V.; Maffulli, N. Metalloproteases and rotator cuff disease. J. Shoulder Elb. Surg. 2012, 21, 200–208. [Google Scholar] [CrossRef]
  17. Longo, U.G.; Rizzello, G.; Petrillo, S.; Loppini, M.; Maffulli, N.; Denaro, V. Conservative rehabilitation provides superior clinical results compared to early aggressive rehabilitation for rotator cuff repair: A retrospective comparative study. Medicina (Kaunas) 2019, 55, 402. [Google Scholar] [CrossRef] [Green Version]
  18. Longo, U.G.; Petrillo, S.; Rizzello, G.; Candela, V.; Denaro, V. Deltoid muscle tropism does not influence the outcome of arthroscopic rotator cuff repair. Musculoskelet. Surg. 2016, 100, 193–198. [Google Scholar] [CrossRef]
  19. Longo, U.G.; Lamberti, A.; Khan, W.S.; Maffulli, N.; Denaro, V. Synthetic augmentation for massive rotator cuff tears. Sports Med. Arthrosc. Rev. 2011, 19, 360–365. [Google Scholar] [CrossRef]
  20. Maffulli, N.; Longo, U.G.; Loppini, M.; Berton, A.; Spiezia, F.; Denaro, V. Tissue engineering for rotator cuff repair: An evidence-based systematic review. Stem Cells Int. 2012, 2012, 418086. [Google Scholar] [CrossRef]
  21. Longo, U.G.; Ciuffreda, M.; Locher, J.; Buchmann, S.; Maffulli, N.; Denaro, V. The effectiveness of conservative and surgical treatment for shoulder stiffness: A systematic review of current literature. Br. Med. Bull. 2018, 127, 111–143. [Google Scholar] [CrossRef]
  22. Longo, U.G.; Franceschi, F.; Berton, A.; Maffulli, N.; Droena, V. Conservative treatment and rotator cuff tear progression. Med. Sport Sci. 2012, 57, 90–99. [Google Scholar]
  23. Longo, U.G.; Petrillo, S.; Candela, V.; Rizzello, G.; Loppini, M.; Maffulli, N.; Denaro, V. Arthroscopic rotator cuff repair with and without subacromial decompression is safe and effective: A clinical study. BMC Musculoskelet. Disord. 2020, 21, 24. [Google Scholar] [CrossRef] [PubMed]
  24. Longo, U.G.; Petrillo, S.; Loppini, M.; Candela, V.; Rizzello, G.; Maffulli, N.; Denaro, V. Metallic versus biodegradable suture anchors for rotator cuff repair: A case control study. BMC Musculoskelet. Disord. 2019, 20, 477. [Google Scholar] [CrossRef]
  25. Shaikh, A.R.; Butte, A.J.; Schully, S.D.; Dalton, W.S.; Khoury, M.J.; Hesse, B.W. Collaborative biomedicine in the age of big data: The case of cancer. J. Med. Internet Res. 2014, 16, e101. [Google Scholar] [CrossRef] [PubMed]
  26. Gorini, A.; Pravettoni, G. P5 medicine: A plus for a personalized approach to oncology. Nat. Rev. Clin. Oncol. 2011, 8, 444. [Google Scholar] [CrossRef] [PubMed]
  27. Pravettoni, G.; Gorini, A. A p5 cancer medicine approach: Why personalized medicine cannot ignore psychology. J. Eval. Clin. Pract. 2011, 17, 594–596. [Google Scholar] [CrossRef] [PubMed]
  28. Maffulli, N.; Margiotti, K.; Longo, U.G.; Loppini, M.; Fazio, V.M.; Denaro, V. The genetics of sports injuries and athletic performance. Muscles Ligaments Tendons J. 2013, 3, 173–189. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  29. Longo, U.G.; Loppini, M.; Margiotti, K.; Salvatore, G.; Berton, A.; Khan, W.S.; Maffulli, N.; Denaro, V. Unravelling the genetic susceptibility to develop ligament and tendon injuries. Curr. Stem Cell Res. 2015, 10, 56–63. [Google Scholar] [CrossRef]
  30. Juengst, E.; McGowan, M.L.; Fishman, J.R.; Settersten, R.A. From “personalized” to “precision” medicine: The ethical and social implications of rhetorical reform in genomic medicine. Hastings Cent. Rep. 2016, 46, 21–33. [Google Scholar] [CrossRef] [Green Version]
  31. Jameson, J.L.; Longo, D.L. Precision medicine—personalized, problematic, and promising. Obstet. Gynecol. Surv. 2015, 70, 612–614. [Google Scholar] [CrossRef]
  32. Maier, M. Personalized medicine—A tradition in general practice! Eur. J. Gen. Pract. 2019, 25, 63. [Google Scholar] [CrossRef]
  33. Favalli, V.; Serio, A.; Giuliani, L.P.; Arbustini, E. ‘Precision and personalized medicine’, a dream that comes true? J. Cardiovasc. Med. 2017, 18, e1–e6. [Google Scholar] [CrossRef]
  34. Ho, D.; Quake, S.R.; McCabe, E.R.; Chng, W.J.; Chow, E.K.; Ding, X.; Gelb, B.D.; Ginsburg, G.S.; Hassenstab, J.; Ho, C.-M. Enabling technologies for personalized and precision medicine. Trends Biotechnol. 2020, 38, 497–518. [Google Scholar] [CrossRef]
  35. Jarow, J.P. Personalized reproductive medicine: Regulatory considerations. Fertil. Steril. 2018, 109, 964–967. [Google Scholar] [CrossRef]
  36. Longo, U.G.; Ambrogioni, L.R.; Berton, A.; Candela, V.; Carnevale, A.; Schena, E.; Gugliemelli, E.; Denaro, V. Physical therapy and precision rehabilitation in shoulder rotator cuff disease. Int. Orthop. 2020, 1–11. [Google Scholar] [CrossRef]
  37. Sebri, V.; Savioni, L. An Introduction to Personalized Ehealth. In P5 Ehealth: An Agenda for the Health Technologies of the Future; Springer: Berlin/Heidelberg, Germany, 2020; pp. 53–70. [Google Scholar]
  38. Juengst, E.T.; McGowan, M.L. Why does the shift from “personalized medicine” to “precision health” and “wellness genomics” matter? AMA J. Ethics 2018, 20, E881–E890. [Google Scholar]
  39. Kondylakis, H.; Koumakis, L.; Mazzocco, K.; Tsiknakis, M.; Marias, K. Participatory Aspects of Ict Infrastructures for Cancer Management. In P5 Ehealth: An Agenda for the Health Technologies of the Future; Springer: Berlin/Heidelberg, Germany, 2020; pp. 87–108. [Google Scholar]
  40. Monzani, D.; Pizzoli, S.F.M. The Prevention of Chronic Diseases through Ehealth: A Practical Overview. In P5 Ehealth: An Agenda for the Health Technologies of the Future; Springer: Berlin/Heidelberg, Germany, 2020; pp. 33–51. [Google Scholar]
  41. Ameln, D.J.D.; Chadwick, E.K.; Blana, D.; Murgia, A. The stabilizing function of superficial shoulder muscles changes between single-plane elevation and reaching tasks. IEEE Trans. Biomed. Eng. 2019, 66, 564–572. [Google Scholar] [CrossRef]
  42. Barlow, J.D.; Bishop, J.Y.; Dunn, W.R.; Kuhn, J.E. What factors are predictors of emotional health in patients with full-thickness rotator cuff tears? J. Shoulder Elb. Surg. 2016, 25, 1769–1773. [Google Scholar] [CrossRef]
  43. Bavan, L.; Surmacz, K.; Beard, D.; Mellon, S.; Rees, J. Adherence monitoring of rehabilitation exercise with inertial sensors: A clinical validation study. Gait Posture 2019, 70, 211–217. [Google Scholar] [CrossRef]
  44. Bonato, L.L.; Quinelato, V.; Pinheiro, A.d.; Amaral, M.V.G.; de Souza, F.N.; Lobo, J.C.; Aguiar, D.P.; Augusto, L.M.M.; Vieira, A.R.; Salles, J.I.; et al. Esrrb polymorphisms are associated with comorbidity of temporomandibular disorders and rotator cuff disease. Int. J. Oral Maxillofac. Surg. 2016, 45, 323–331. [Google Scholar] [CrossRef]
  45. Camurcu, Y.; Ucpunar, H.; Ari, H.; Duman, S.; Cobden, A.; Sofu, H. Predictors of allocation to surgery in patients older than 50 years with partial-thickness rotator cuff tear. J. Shoulder Elb. Surg. 2019, 28, 828–832. [Google Scholar] [CrossRef]
  46. Carbonaro, N.; Lucchesi, I.; Lorusssi, F.; Tognetti, A. Tele-Monitoring and Tele-Rehabilitation of The Shoulder Muscular-Skeletal Diseases Through Wearable Systems. In Proceedings of the 2018 40th Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC), Honolulu, HI, USA, 18–21 July 2018; Volume 2018, pp. 4410–4413. [Google Scholar]
  47. Chiu, C.H.; Chen, P.; Yeh, W.L.; Chen, A.C.; Chan, Y.S.; Hsu, K.Y.; Lei, K.F. The gelling effect of platelet-rich fibrin matrix when exposed to human tenocytes from the rotator cuff in small-diameter culture wells and the design of a co-culture device to overcome this phenomenon. Bone Jt. Res. 2019, 8, 216–223. [Google Scholar] [CrossRef]
  48. George, S.Z.; Staud, R.; Borsa, P.A.; Wu, S.S.; Wallace, M.R.; Greenfield, W.H.; Mackie, L.N.; Fillingim, R.B. Biopsychosocial influence on shoulder pain: Rationale and protocol for a pre-clinical trial. Contemp. Clin. Trials 2017, 56, 9–17. [Google Scholar] [CrossRef] [Green Version]
  49. Jeong, H.Y.; Kim, H.J.; Jeon, Y.S.; Rhee, Y.G. Factors predictive of healing in large rotator cuff tears: Is it possible to predict retear preoperatively? Am. J. Sports Med. 2018, 46, 1693–1700. [Google Scholar] [CrossRef]
  50. Kang, Y.; Lee, G.Y.; Lee, J.W.; Lee, E.; Kim, B.; Kim, S.J.; Ahn, J.M.; Kang, H.S. Texture analysis of torn rotator cuff on preoperative magnetic resonance arthrography as a predictor of postoperative tendon status. Korean J. Radiol. 2017, 18, 691–698. [Google Scholar] [CrossRef] [Green Version]
  51. Matcuk, G.R., Jr.; Moin, P.; Cen, S. Shoulder measurements on mri: Statistical analysis of patients without and with rotator cuff tears and predictive modeling. Clin. Anat. 2020, 33, 173–186. [Google Scholar] [CrossRef]
  52. Zheng, M.; Qian, Z.; Zou, Z.; Peach, C.; Ren, L. Subject-specific finite element modeling of the human shoulder complex part 2: Quantitative evaluation of the effect of rotator cuff tear propagation on glenohumeral joint stability. IEEE Access 2019, 7, 34068–34077. [Google Scholar] [CrossRef]
  53. Sakamoto, Y.; Kido, A.; Inoue, K.; Sakurai, G.; Hashiuchi, T.; Munemoto, M.; Tanaka, Y. In vivo microstructural analysis of the humeral greater tuberosity in patients with rotator cuff tears using multidetector row computed tomography. BMC Musculoskelet. Disord. 2014, 15, 351. [Google Scholar] [CrossRef] [Green Version]
  54. Tashjian, R.Z.; Granger, E.K.; Farnham, J.M.; Cannon-Albright, L.A.; Teerlink, C.C. Genome-wide association study for rotator cuff tears identifies two significant single-nucleotide polymorphisms. J. Shoulder Elb. Surg. 2016, 25, 174–179. [Google Scholar] [CrossRef]
  55. Santurro, A.; Maria Vullo, A.; Borro, M.; Gentile, G.; La Russa, R.; Simmaco, M.; Frati, P.; Fineschi, V. Personalized medicine applied to forensic sciences: New advances and perspectives for a tailored forensic approach. Curr. Pharm. Biotechnol. 2017, 18, 263–273. [Google Scholar] [CrossRef]
  56. Khoury, M.J.; Gwinn, M.L.; Glasgow, R.E.; Kramer, B.S. A population approach to precision medicine. Am. J. Prev. Med. 2012, 42, 639–645. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  57. Alonso, S.G.; de la Torre Díez, I.; Zapiraín, B.G. Predictive, personalized, preventive and participatory (4p) medicine applied to telemedicine and ehealth in the literature. J. Med. Syst. 2019, 43, 140. [Google Scholar] [CrossRef] [PubMed]
  58. World Health Organization. Global Diffusion of Ehealth: Making Universal Health Coverage Achievable: Report of the Third Global Survey on Ehealth; World Health Organization: Geneva, Switzerland, 2017. [Google Scholar]
  59. de Paiva Azevedo, J.; Delaney, H.; Epperson, M.; Jbeili, C.; Jensen, S.; McGrail, C.; Weaver, H.; Baglione, A.; Barnes, L.E. Gamification of Ehealth Interventions to Increase User Engagement and Reduce Attrition. In Proceedings of the 2019 Systems and Information Engineering Design Symposium (SIEDS), Charlottesville, VA, USA, 26–26 April 2019; pp. 1–5. [Google Scholar]
  60. Wang, Q.; Markopoulos, P.; Yu, B.; Chen, W.; Timmermans, A. Interactive wearable systems for upper body rehabilitation: A systematic review. J. Neuroeng. Rehabil 2017, 14, 20. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  61. Triberti, S.; Brivio, E. User-Centered Design Approaches and Methods for p5 Ehealth. In P5 Ehealth: An Agenda for the Health Technologies of the Future; Springer: Berlin/Heidelberg, Germany, 2020; pp. 155–171. [Google Scholar]
  62. Vicini, P.; Fields, O.; Lai, E.; Litwack, E.; Martin, A.M.; Morgan, T.; Pacanowski, M.; Papaluca, M.; Perez, O.; Ringel, M. Precision medicine in the age of big data: The present and future role of large-scale unbiased sequencing in drug discovery and development. Clin. Pharmacol. Ther. 2016, 99, 198–207. [Google Scholar] [CrossRef] [PubMed]
  63. Longo, U.G.; Margiotti, K.; Petrillo, S.; Rizzello, G.; Fusilli, C.; Maffulli, N.; De Luca, A.; Denaro, V. Genetics of rotator cuff tears: No association of col5a1 gene in a case-control study. BMC Med. Genet. 2018, 19, 217. [Google Scholar] [CrossRef]
  64. Maffulli, N.; Longo, U.G.; Berton, A.; Loppini, M.; Denaro, V. Biological factors in the pathogenesis of rotator cuff tears. Sports Med. Arthrosc. Rev. 2011, 19, 194–201. [Google Scholar] [CrossRef]
  65. Longo, U.G.; Rizzello, G.; Berton, A.; Maltese, L.; Fumo, C.; Khan, W.S.; Denaro, V. Biological strategies to enhance rotator cuff healing. Curr. Stem Cell Res. 2013, 8, 464–470. [Google Scholar] [CrossRef]
  66. Kinkorová, J. Biobanks in the era of personalized medicine: Objectives, challenges, and innovation. EPMA J. 2016, 7, 4. [Google Scholar] [CrossRef] [Green Version]
  67. Zumstein, M.A.; Lädermann, A.; Raniga, S.; Schär, M.O. The biology of rotator cuff healing. Orthop. Traumatol. Surg. Res. 2017, 103, S1–S10. [Google Scholar] [CrossRef]
  68. Dabija, D.I.; Gao, C.; Edwards, T.L.; Kuhn, J.E.; Jain, N.B. Genetic and familial predisposition to rotator cuff disease: A systematic review. J. Shoulder Elb. Surg. 2017, 26, 1103–1112. [Google Scholar] [CrossRef]
  69. Franceschi, F.; Longo, U.G.; Ruzzini, L.; Rizzello, G.; Maffulli, N.; Denaro, V. Soft tissue tenodesis of the long head of the biceps tendon associated to the roman bridge repair. BMC Musculoskelet. Disord. 2008, 9, 78. [Google Scholar] [CrossRef] [Green Version]
  70. Franceschi, F.; Longo, U.G.; Ruzzini, L.; Rizzello, G.; Denaro, V. Arthroscopic management of calcific tendinitis of the subscapularis tendon. Knee Surg. Sports Traumatol. Arthrosc. 2007, 15, 1482–1485. [Google Scholar] [CrossRef]
  71. Longo, U.G.; Franceschi, F.; Spiezia, F.; Marinozzi, A.; Maffulli, N.; Denaro, V. The low-profile roman bridge technique for knotless double-row repair of the rotator cuff. Arch. Orthop. Trauma Surg. 2011, 131, 357–361. [Google Scholar] [CrossRef]
  72. Franceschi, F.; Longo, U.G.; Ruzzini, L.; Rizzello, G.; Maffulli, N.; Denaro, V. The roman bridge: A “double pulley-suture bridges” technique for rotator cuff repair. BMC Musculoskelet. Disord. 2007, 8, 123. [Google Scholar] [CrossRef] [Green Version]
  73. Maffulli, N.; Longo, U.G. Conservative management for tendinopathy: Is there enough scientific evidence? Rheumatology (Oxford) 2008, 47, 390–391. [Google Scholar] [CrossRef] [Green Version]
  74. Longo, U.G.; Berton, A.; Khan, W.S.; Maffulli, N.; Denaro, V. Histopathology of rotator cuff tears. Sports Med. Arthrosc. Rev. 2011, 19, 227–236. [Google Scholar] [CrossRef]
Jpm 11 00255 g001 550
Figure 1. P5 medicine’s steps towards the optimal management of rotator cuff diseases.
Figure 1. P5 medicine’s steps towards the optimal management of rotator cuff diseases.
Jpm 11 00255 g001
Table
Table 1. Approaches of the personalized, predictive, participatory, precision and preventive (P5) medicine model.
Table 1. Approaches of the personalized, predictive, participatory, precision and preventive (P5) medicine model.
Approach of P5
Medicine		Definition
PersonalizedTo identify tailored intervention based on the genetic profile of each individual, also considering other factors such as patients’ abilities, contexts, needs, social condition, lifestyle, family history, concomitant therapies, and psychological aspects [8,35,37].
PredictiveTo exploit laboratory and genetic tests to predict the onset of a disease, and the deterioration or amelioration of a disease, by applying techniques and methods such as biomedical imaging instruments, artificial intelligence, and machine learning [7].
ParticipatoryTo involve individuals in the management of their health status, strengthening the patients’ empowerment, autonomy, and engagement, and fostering the communication between multiple actors such as patients, doctors, and caregivers [39].
PrecisionTo classify patients with a disease into subgroups, considering their phenotypic findings, such as biomarkers or genomics [35].
PreventiveTo define interventions for a specific pathology or disease before they occur, considering not only biological aspects but also environmental, social, and psychological aspects [40].
Table
Table 2. Studies related to personalized, predictive, participatory, precision, and preventive approaches in the management of rotator cuff diseases. In light blue are highlighted the aspects of the P5 medicine approach emerging from each study.
Table 2. Studies related to personalized, predictive, participatory, precision, and preventive approaches in the management of rotator cuff diseases. In light blue are highlighted the aspects of the P5 medicine approach emerging from each study.
First Author, Year of PublicationPersonalizedPredictiveParticipatoryPrecisionPreventiveMain PurposeConclusions
Ameln, 2018 [41] To use a musculoskeletal model, comprising a personalized scapulohumeral rhythm, to determine the stabilizing role of RC and selected superficial shoulder muscles as a function of humeral elevation and the plane of elevation.The RC muscles provide greater compression than shear forces during tasks; the findings can be applied to understand how shear and compressive forces change in populations with abnormal shoulder motion.
Barlow, 2016 [42] To establish factors most predictive of poor emotional health in patients with FTRCTsEducation level, employment status, pain levels, and patient perception of the percentage of shoulder normalcy were most predictive of emotional health in patients with FTRCTs.
Bavan, 2019 [43] Demonstrating treatment fidelity to draw conclusions about the efficacy of rehabilitation interventions in both clinical and research settingsClassification models differentiated well patient exercise activity from non-specific movement by using inertial sensor data. Home rehabilitation could improve patient engagement.
Bonato, 2016 [44] To investigate the association between TMD and RC disease and related genetic aspects.TMD is a risk factor for RC disease. ESRRB haplotypes and low muscle activity are common biomechanical characteristics in subjects with both diseases.
Camurcu, 2019 [45] To determine the predictive factors for allocation to surgery in patients older than 50 years with symptomatic chronic PTRCT. Patients with fewer comorbidities and bursal-sided PTRCTs were significantly more likely to undergo surgery.
Carbonaro, 2018 [46] To test a wearable technology-enabled platform for remote rehabilitation.The proposed approach provides the patient and the therapist with relevant feedback on the quality of personalized rehabilitation.
Chiu, 2019 [47] To develop a screening method for personalized best-fit PRFM to test as many tenocyte/PRFM interactions as possible.The proposed platform could be used to screen personalized best-fit PRFM preparation protocols according to disease stage and severity.
George, 2017 [48] To test the mechanisms and efficacy of personalized pain interventions matched to genetic and psychological characteristics.This is a meaningful advance towards personalized or targeted treatments for musculoskeletal pain.
Jeong, 2018 [49] To determine the risk factors related to retear after arthroscopic RC repair, to evaluate whether it is possible to predict the occurrence of retear preoperatively.Predicting retear preoperatively may help surgeons determine the proper treatment and predict the postoperative prognosis.
Kang, 2017 [50] To evaluate texture data of the torn supraspinatus tendon for prediction of the postoperative tendon state.Texture analysis may be helpful to predict postoperative tendon state after RC repair.
Matcuk, 2019 [51] To create predictive models to distinguish patients with RC tears from those without.The proper combination of measurements on shoulder MRIs may be able to separate patients with RC tears from those without.
Zheng, 2019 [52] To evaluate the effects of RC tear propagation on glenohumeral joint stability in a subject-specific finite element model of the shoulder complex.This type of investigation can predict shoulder biomechanics, and can also be used to improve diagnostic and therapeutic strategies for clinicians.
Sakamoto, 2014 [53] To evaluate the microstructure of the greater tuberosity of the humeral head in patients with RC tears, and to explore individual and regional variance of bone quality in vivo.The proposed method can help to understand the individual and regional variance in bone quality and may lead to the creation of personalized surgical protocols.
Tashjian, 2016 [54] To identify specific genes or genetic variants associated with rotator cuff tearing by a genome-wide association study.Identification of potential genes or genetic variants associated with rotator cuff tearing may help in identifying individuals at risk of the development of rotator cuff tearing.
RC: rotator cuff, FTRCTs: full-thickness rotator cuff tears, TMD: temporo-mandibular disorders, ESRRB: estrogen-related receptor β, PTRCT: partial-thickness rotator cuff tear, PRFM: platelet-rich fibrin matrix.
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Longo, U.G.; Carnevale, A.; Massaroni, C.; Lo Presti, D.; Berton, A.; Candela, V.; Schena, E.; Denaro, V. Personalized, Predictive, Participatory, Precision, and Preventive (P5) Medicine in Rotator Cuff Tears. J. Pers. Med. 2021, 11, 255. https://doi.org/10.3390/jpm11040255

AMA Style

Longo UG, Carnevale A, Massaroni C, Lo Presti D, Berton A, Candela V, Schena E, Denaro V. Personalized, Predictive, Participatory, Precision, and Preventive (P5) Medicine in Rotator Cuff Tears. Journal of Personalized Medicine. 2021; 11(4):255. https://doi.org/10.3390/jpm11040255

Chicago/Turabian Style

Longo, Umile Giuseppe, Arianna Carnevale, Carlo Massaroni, Daniela Lo Presti, Alessandra Berton, Vincenzo Candela, Emiliano Schena, and Vincenzo Denaro. 2021. "Personalized, Predictive, Participatory, Precision, and Preventive (P5) Medicine in Rotator Cuff Tears" Journal of Personalized Medicine 11, no. 4: 255. https://doi.org/10.3390/jpm11040255

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop